// App-Quantinova.ai

: Efficacy Of Hydroxychloroquine in Refractory Chronic Idiopathic Urticaria (RCIU)

Researchers

Presenter

  • Najeeb Khan

Principal Investigators

  • Tolly Epstein

  • Ilona DeBuske

  • Maria Strobel

  • David Bernstein

Medical Centers

  • University of Cincinnati, Cincinnati, Ohio

  • University of Cincinnati, Allergy Partners of Central Indiana, Indianapolis, Indiana

  • Indiana University School of Medicine, Indianapolis, Indiana

  • University of Cincinnati & Bernstein Allergy Group, Cincinnati, Ohio

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Omalizumab

Outcome

  • N/A

Study Design

  • Efficacy

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved